PRIME MEDICINE INC (PRME) Stock Cash Flow
NASDAQ:PRME - Nasdaq - US74168J1016 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -202.01M | -195.88M | -198.13M | -121.82M | -165.37M | |||
| Depreciation Amortization | 6.51M | 6.13M | 4.65M | 2.22M | 570.00K | |||
| Income Taxes - Deferred | -134.00K | 0.00 | -279.00K | -960.00K | -620.00K | |||
| Change In Working Capital | 53.53M | 31.08M | 2.65M | -35.40M | 31.18M | |||
| Taxes Paid | N/A | N/A | 0.00 | 140.00K | N/A | |||
| Other non cash items | 38.08M | 35.81M | 25.70M | 24.14M | 100.17M | |||
| OPERATING CASH FLOW | -104.02M | -122.86M | -165.41M | -131.83M | -34.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.39M | -7.29M | -8.72M | -16.10M | -4.15M | |||
| Other Investing Activity | 65.14M | 75.75M | 27.43M | -31.00M | -69.48M | |||
| INVESTING CASH FLOW | 57.75M | 68.46M | 18.71M | -47.10M | -73.63M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 38.55M | 189.88M | 655.00K | 185.54M | 270.36M | |||
| Other Financing Activity | 6.00M | 6.00M | 0.00 | -4.04M | -1.09M | |||
| FINANCING CASH FLOW | 44.55M | 195.88M | 655.00K | 181.49M | 269.28M | |||
| CHANGE IN CASH | -1.72M | 141.47M | -146.05M | 2.56M | 161.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -104.02M | -122.86M | -165.41M | -131.83M | -34.08M | |||
| Capital Expenditure | -7.39M | -7.29M | -8.72M | -16.10M | -4.15M | |||
| FREE CASH FLOW | -111.41M | -130.16M | -174.14M | -147.93M | -38.23M | |||
All data in USD